Latest news

Search
Categories
News archive

Nanologica Announces Outcome of Rights Issue

The Board of Directors of Nanologica AB (publ) (“Nanologica” or the “Company”) today announces the outcome of the Company’s rights issue of units of approximately SEK 110.5 million (the “Rights Issue”), for which the subscription period ended on 17 November 2026. The Rights Issue has been subscribed to approximately 38.76 percent with and without the support of unit rights, of which approximately 38.69 percent was subscribed for with the support of unit rights and approximately

Read more »

Nanologica Announces Nomination Committee for the Annual General Meeting 2027

In accordance with the current nomination committee instructions, the chairman of the board has contacted Nanologica’s three largest shareholders or owner groups in terms of voting rights as of September 30, 2026, each of whom has been offered to appoint a representative to constitute the nomination committee of Nanologica AB for the 2027 Annual General Meeting. The nomination committee for Nanologica AB’s AGM 2027 thus consists of the following three members: Carl-Johan Spak (Flerie Invest

Read more »

Mark Quick Assumes CEO Position at Nanologica AB

On October 23, 2026, Nanologica AB (publ) announced that Mark Quick has been appointed as the new CEO, provided that the Swedish Companies Registration Office grants an exemption from the requirement of residence in the EEA pursuant to Chapter 8, Section 30 of the Swedish Companies Act (2005:551). The Swedish Companies Registration Office has now granted an exemption, and Mark Quick has assumed the position as CEO. The exemption is valid until November 30, 2027,

Read more »

Subscription period 3-17 November 2026

On 23 October 2026, The Board of Nanologica AB resolved on a rights issue of appx SEK 110,5 million.  The rights issue is guaranteed to 77,6 percent. The subscription period runs between 3-17 November 2026. Subscription is made via https://bergssecurities.se/issuer-service-transaction/nanologica-ab-publ-2/ More information regarding the rights issue can be found here.

Read more »

Nanologica resolves on a partially guaranteed rights issue of units of appx. SEK 110.5 million

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION REQUIRES A PROSPECTUS, REGISTRATION OR OTHER MEASURES OTHER THAN THOSE REQUIRED BY SWEDISH LAW, IS PROHIBITED, OR OTHERWISE CONTRAVENES APPLICABLE RULES IN SUCH JURISDICTION OR CANNOT BE MADE WITHOUT THE APPLICATION OF AN EXEMPTION FROM SUCH MEASURE. SEE

Read more »